CLINICAL_TRIALS
trial_result
· 2013-04-16
Clinical Trial Update: Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 trial of pomalidomide (CC-4047) in advanced soft tissue sarcoma has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2013-04-16